Talphera (TLPH) Inventory Average (2016 - 2022)
Talphera (TLPH) posted Inventory Average of $1.0 million for Q4 2022, up 15.61% on a QoQ basis from $887500.0 in Q3 2022, and down 23.06% year-over-year from $1.3 million in Q4 2021.
Analysis
Talphera (TLPH) Inventory Average (2016 - 2022) Analysis & Trends
Talphera has reported Inventory Average for 7 years, with the latest figure at $1.0 million in Q4 2022.
- On a quarterly basis, Inventory Average fell 23.06% year-over-year to $1.0 million in Q4 2022; TTM through Dec 2022 was $1.0 million, a 23.06% decrease from a year earlier, with the FY2022 full-year figure at $1.1 million, down 16.37% from the prior year.
- Inventory Average was $1.0 million for Q4 2022 at Talphera, up from $887500.0 in the prior quarter.
- The five-year high for Inventory Average was $3.2 million in Q1 2020, with the low at $664500.0 in Q2 2018.
- Average Inventory Average over 5 years is $1.7 million, with a median of $1.4 million recorded in 2021.
- The sharpest annual moves came in 2018 and 2019: Inventory Average tumbled 61.28% in 2018, then soared 294.81% in 2019.
- Over 5 years, Inventory Average stood at $855000.0 in 2018, then jumped by 266.96% to $3.1 million in 2019, then slumped by 42.5% to $1.8 million in 2020, then declined by 26.08% to $1.3 million in 2021, then slipped by 23.06% to $1.0 million in 2022.
- The last three Inventory Average figures came in at $1.0 million (Q4 2022), $887500.0 (Q3 2022), and $973000.0 (Q2 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 887,500.00 |
| Jun 30, 2022 | 973,000.00 |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 1.39 Mn |
| Mar 31, 2021 | 1.52 Mn |
| Dec 31, 2020 | 1.80 Mn |
| Sep 30, 2020 | 2.31 Mn |
| Jun 30, 2020 | 2.87 Mn |
| Mar 31, 2020 | 3.20 Mn |
| Dec 31, 2019 | 3.14 Mn |
| Sep 30, 2019 | 2.91 Mn |
| Jun 30, 2019 | 2.62 Mn |
| Mar 31, 2019 | 1.63 Mn |
| Dec 31, 2018 | 855,000.00 |
| Sep 30, 2018 | 759,500.00 |
| Jun 30, 2018 | 664,500.00 |
| Mar 31, 2018 | 811,000.00 |